Narrow-band imaging Dual focus endoscopy capabilities in diff erential diagnosis of intestinal metaplasia types

Stomach cancer has an important place in medicine. Unfortunately, diagnosis of gastric cancer is being established in majority of cases at the IV stage. So, yt is necessary to detect tumors at the earliest stages of carcinogenesis and to evaluate and treat precancerous diseases, such as gastric atrophy and intestinal metaplasia.
Aims: To estimate the value of Narrow-band imaging Dual focus (NBI Dual Focus) endoscopy capabilities in differential diagnosis of intestinal metaplasia types. We evaluated the data of Russian and foreign articles on this topic from 2011 to 2021. In our study 46 patients with suspected intestinal metaplasia admitted to Nizhny Novgorod Oncology Dispensary. We have performed multimodal endoscopy, including White light endoscopy (WLI), narrow-band imaging (NBI, WLI, BLI — 28) and Dual focus endoscopy (18). Sydney system based multifocal biopsy and targeted biopsy of IM foci were performed in all cases.
Results: Verification of intestinal metaplasia, visualized with WLI, was confirmed in only 59% cases. However, intestinal metaplasia, observed with NBI, was confirmed by pathology in 100% cases. NBI Dual Focus endoscopy made possible to differentiate complete and incomplete intestinal metaplasia also in all patients.
Conclusions: Intestinal metaplasia can be successfully diagnosed with NBI endoscopy. Differential diagnosis of types of intestinal metaplasia and other variants of gastric mucosa metaplasia is possible using narrow-spectrum endoscopy with dual focus (NBI Dual Focus).

1. Kaprin A.D., Starinsky V. V., Shakhzadova A. O. Th e state of oncological care for the population of Russia in 2020. Moscow. MNIOI im. P. A. Herzen – branch of the Federal State Budgetary Institution “NMITs Radiology” of the Ministry of Health of Russia Publ., 2021. Ill, 239 p. (in Russ.)

2. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 Jul 1;48(13):3554–60. PMID:3288329.

3. El-Zimaity H.M., Ramchatesingh J., Saeed M. A., Graham D. Y. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001;54(9):679–683. doi:10.1136/jcp.54.9.679

4. González C.A., Sanz-Anquela J.M., Gisbert J. P., Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133(5):1023–1032. doi:10.1002/ijc.28003

5. Zullo A., Hassan C., Romiti A., et al. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol. 2012;4(3):30–36. doi:10.4251/wjgo.v4.i3.30

6. Panteris V., Nikolopoulou S., Lountou A., Triantafillid is J. K. Diagnostic capabilities of high-definition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data. Eur J Gastroenterol Hepatol. 2014;26(6):594–601. doi:10.1097/MEG.0000000000000097

7. Pirogov S.S. [Multimodal ultra-high magnifi cation endoscopy in the diagnosis of early cancer and precancerous diseases of the stomach. Dr. med. sci. diss]. Kaluga, 2019. (in Russ)

8. Kanemitsu T., Yao K., Nagahama T., et al. Extending magnifying NBI diagnosis of intestinal metaplasia in the stomach: the white opaque substance marker. Endoscopy. 2017;49(6):529–535. doi:10.1055/s-0043–103409

9. Uedo N., Ishihara R., Iishi H., et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy. 2006;38(8):819–824. doi:10.1055/s-2006–944632

10. Chen H., Wu X., Liu Y., Wu Q., Lu Y., Li C. Blue laser imaging with acetic acid enhancement improved the detection rate of gastric intestinal metaplasia. Lasers Med Sci. 2019;34(3):555–559. doi:10.1007/s10103–018–2629-z

11. Castro R., Rodriguez M., Libânio D., et al. Reliability and accuracy of blue light imaging for staging of intestinal metaplasia in the stomach. Scand J Gastroenterol. 2019;54(11):1301–1305. doi:10.1080/00365521.2019.1684555

12. Song J., Zhang J., Wang J., et al. Meta-analysis: narrow band imaging for diagnosis of gastric intestinal metaplasia. PLoS One. 2014;9(4): e94869. Published 2014 Apr 17. doi:10.1371/journal.pone.0094869

13. Zhu Y., Wang F., Zhou Y., et al. Blue laser magnifying endoscopy in the diagnosis of chronic gastritis. Exp Ther Med. 2019;18(3):1993–2000. doi:10.3892/etm.2019.7811

14. Lage J., Pimentel- Nunes P., Figueiredo P. C., et al. Light-NBI to identify high-risk phenotypes for gastric adenocarcinoma: do we still need biopsies?. Scand J Gastroenterol. 2016;51(4):501–506. doi:10.3109/00365521.2015.1101779